Heparins, low molecular weight heparins, and pentasaccharides
D.L. Dinwoodey, J.E. Ansell
pág. 1
Preface
Laurie G. Jacobs
pág. 13
Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the eldery
pág. 17
New anticoagulant agents: direct thrombin inhibitors
E.A. Nutescu, N.L. Shapiro, A. Chevalier
pág. 33
Antiplatelet agents and arterial thrombosis
H.H. Billett
pág. 57
Pathophysiology of venous thrombosis, thrombophilia, and the diagnosis of deep vein thrombosis pulmonary embolism in the elderly
G.J. Merli
pág. 75
Prevention of venous thromboembolism in the geriatric patient
Amir K. Jaffer, Daniel J. Brotman
pág. 93
Anticoagulant treatment of deep vein thrombosis and pulmonary embolism
H. Tran, S. McRae, J. Ginsberg
pág. 113
Antithrombotic and thrombolytic therapy for ischemic stroke
D.M. Rosenbaum, L.C. Ocava, M. Singh, S. Malhorta
pág. 135
Antithrombotic therapy in atrial fibrillation
D.A. Garcia, E. Hylek
pág. 155
Chronic antihrombotic therapy in post myocardial infarction patients
S. Sodhi, R. Lee, M. Ezekowitz
pág. 167
Antithrombotic therapy in peripheral arterial disease
E.C. Lipsitz, Soo Kim
pág. 183
Perioperative management of oral anticoagulation
M. Oï¿œDonnell, C. Kearon
pág. 199
Index
pág. 215
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: